MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Uncover Familial Dysalbuminemic Hyperthyroxinemia with genetic testing. Identify albumin gene mutations like R222I for accurate diagnosis and better management.
Explore the genetic basis of Hypogonadotropic Hypogonadism 22, its link to Kallmann syndrome, and how genetic testing aids in diagnosis, treatment, and family planning.
Explore how genetic testing aids in early diagnosis, personalized treatment, and family planning for Hypomyelinating Leukodystrophy 9, improving patient outcomes.
Unlock the potential of genetic testing in diagnosing Hypotrichosis 13, offering insights into genetic mutations and guiding personalized treatment and family planning.
Explore the impact of genetic testing on diagnosing Immunodeficiency 36, early detection, personalized treatment, and family planning for better patient outcomes.
Explore advanced genetic testing for NISBD2, a rare neonatal inflammatory disorder. Learn how precision diagnosis and personalized treatment offer hope for families.
Genetic testing for IDAD29 offers early detection, personalized care, and informed family planning, enhancing life quality for those affected by this hereditary condition.
Genetic testing transforms ID-AD 30 diagnosis by pinpointing variants, enabling early intervention, and guiding family planning for improved patient outcomes.